Literature DB >> 22613061

Long-term exposure to hexavalent chromium inhibits expression of tumor suppressor genes in cultured cells and in mice.

Yunxia Fan1, Jerald L Ovesen, Alvaro Puga.   

Abstract

We have used mouse hepatoma cells in culture to study acute, short-term high-dose effects of hexavalent chromium on gene regulation directed by the polycyclic aromatic hydrocarbon benzo[a]pyrene (BaP). We find that the mixture engages three major signaling pathways: (i) activation of detoxification genes; (ii) induction of signal transduction effectors; and (iii) epigenetic modification of chromatin marks. Preliminary results in mice exposed to mixtures of low doses of Cr(VI) plus BaP indicate that all three pathways are likely to be engaged also in long-term effects resulting from exposure to environmentally relevant doses of the mixture that inhibit the expression of tumor suppressor genes. Given the toxicity and carcinogenicity of these mixtures, we expect that a two-way analytical approach, from cells in culture to biological effects in vivo and vice versa, will provide a better understanding of the molecular mechanisms responsible for the biological effects of mixtures. By focusing both the in vivo and the in vitro work into long-term, low-dose, environmentally relevant exposures, we expect to develop much needed information pertinent to the type of diseases found in human populations exposed to mixtures of environmental toxicants.
Copyright © 2012 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22613061      PMCID: PMC3380135          DOI: 10.1016/j.jtemb.2012.04.009

Source DB:  PubMed          Journal:  J Trace Elem Med Biol        ISSN: 0946-672X            Impact factor:   3.849


  31 in total

1.  Mechanisms of chromium-induced suppression of RNA synthesis in cellular and cell-free systems: relationship to RNA polymerase arrest.

Authors:  Jian Xu; Francis C R Manning; Travis J O'Brien; Susan Ceryak; Steven R Patierno
Journal:  Mol Cell Biochem       Date:  2004-01       Impact factor: 3.396

2.  Chromium(VI) inhibits the transcriptional activity of nuclear factor-kappaB by decreasing the interaction of p65 with cAMP-responsive element-binding protein-binding protein.

Authors:  J A Shumilla; R J Broderick; Y Wang; A Barchowsky
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

3.  Differential effects of chromium(VI) on constitutive and inducible gene expression in chick embryo liver in vivo and correlation with chromium(VI)-induced DNA damage.

Authors:  J W Hamilton; K E Wetterhahn
Journal:  Mol Carcinog       Date:  1989       Impact factor: 4.784

4.  Arsenic co-exposure potentiates benzo[a]pyrene genotoxicity.

Authors:  Andrew Maier; Brenda L Schumann; Xiaoqing Chang; Glenn Talaska; Alvaro Puga
Journal:  Mutat Res       Date:  2002-05-27       Impact factor: 2.433

5.  Toxicity characterization of complex mixtures using biological and chemical analysis in preparation for assessment of mixture similarity.

Authors:  Leslie Cizmas; Thomas J McDonald; Tracie D Phillips; Annika M Gillespie; Rebecca A Lingenfelter; Leon F Kubena; Timothy D Phillips; Kirby C Donnelly
Journal:  Environ Sci Technol       Date:  2004-10-01       Impact factor: 9.028

6.  Lower mutagenicity but higher stability of Cr-DNA adducts formed during gradual chromate activation with ascorbate.

Authors:  George Quievryn; Joseph Messer; Anatoly Zhitkovich
Journal:  Carcinogenesis       Date:  2006-05-19       Impact factor: 4.944

7.  Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer.

Authors:  Sonata Jarmalaite; Annamaria Kannio; Sisko Anttila; Juozas R Lazutka; Kirsti Husgafvel-Pursiainen
Journal:  Int J Cancer       Date:  2003-10-10       Impact factor: 7.396

8.  Chromium(VI) exposure enhances polycyclic aromatic hydrocarbon-DNA binding at the p53 gene in human lung cells.

Authors:  Zhaohui Feng; Wenwei Hu; William N Rom; Max Costa; Moon-Shong Tang
Journal:  Carcinogenesis       Date:  2003-04       Impact factor: 4.944

9.  The ATM-SMC1 pathway is essential for activation of the chromium[VI]-induced S-phase checkpoint.

Authors:  Timothy P Wakeman; Wan-Ju Kim; Shannon Callens; Arthur Chiu; Kevin D Brown; Bo Xu
Journal:  Mutat Res       Date:  2004-10-04       Impact factor: 2.433

10.  Chromium (VI) activates ataxia telangiectasia mutated (ATM) protein. Requirement of ATM for both apoptosis and recovery from terminal growth arrest.

Authors:  Linan Ha; Susan Ceryak; Steven R Patierno
Journal:  J Biol Chem       Date:  2003-03-10       Impact factor: 5.157

View more
  8 in total

Review 1.  Chromium exposure disrupts chromatin architecture upsetting the mechanisms that regulate transcription.

Authors:  Hesbon A Zablon; Andrew VonHandorf; Alvaro Puga
Journal:  Exp Biol Med (Maywood)       Date:  2019-04-01

2.  Long-term Coexposure to Hexavalent Chromium and B[a]P Causes Tissue-Specific Differential Biological Effects in Liver and Gastrointestinal Tract of Mice.

Authors:  Francisco Javier Sánchez-Martín; Yunxia Fan; Vinicius Carreira; Jerald L Ovesen; Andrew Vonhandorf; Ying Xia; Alvaro Puga
Journal:  Toxicol Sci       Date:  2015-03-29       Impact factor: 4.849

3.  Hexavalent chromium increases the metabolism and genotoxicity of aromatic amine carcinogens 4-aminobiphenyl and β-naphthylamine in immortalized human lung epithelial cells.

Authors:  James T F Wise; Raúl A Salazar-González; Kennedy M Walls; Mark A Doll; Mariam R Habil; David W Hein
Journal:  Toxicol Appl Pharmacol       Date:  2022-06-02       Impact factor: 4.460

4.  Hexavalent chromium promotes differential binding of CTCF to its cognate sites in Euchromatin.

Authors:  Andrew VonHandorf; Hesbon A Zablon; Jacek Biesiada; Xiang Zhang; Mario Medvedovic; Alvaro Puga
Journal:  Epigenetics       Date:  2021-01-07       Impact factor: 4.528

Review 5.  Mineral Micronutrients in Asthma.

Authors:  Dominika Zajac
Journal:  Nutrients       Date:  2021-11-10       Impact factor: 5.717

6.  Opinion controversy to chromium picolinate therapy's safety and efficacy: ignoring 'anecdotes' of case reports or recognising individual risks and new guidelines urgency to introduce innovation by predictive diagnostics?

Authors:  Olga Golubnitschaja; Kristina Yeghiazaryan
Journal:  EPMA J       Date:  2012-10-07       Impact factor: 6.543

Review 7.  Cytogenomics of hexavalent chromium (Cr 6+) exposed cells: a comprehensive review.

Authors:  Akanksha Nigam; Shivam Priya; Preeti Bajpai; Sushil Kumar
Journal:  Indian J Med Res       Date:  2014-03       Impact factor: 2.375

Review 8.  Hexavalent chromium disrupts chromatin architecture.

Authors:  Andrew VonHandorf; Hesbon A Zablon; Alvaro Puga
Journal:  Semin Cancer Biol       Date:  2021-07-15       Impact factor: 15.707

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.